Improving access to cancer care: a first analysis of pharmaceutical company actions in low and middle income countries
This study from the Access to Medicine Foundation analyses how large pharmaceutical companies are addressing access to cancer care in poor countries. It finds 16 companies taking action, with 129 separate pricing and capacity building initiatives.